Roche commits to diabetes testing and sees 2017 return to growth

Roche tablets are seen positioned in front of a displayed Roche logo in this photo illustrationBy Ben Hirschler LONDON (Reuters) – Roche has no plans to sell its diabetes testing business, despite a pummeling in the past three years from U.S. price cuts, and the Swiss drugmaker expects the unit to return to sales growth in 2017. Roland Diggelmann, head of Roche diagnostics, said the fundamentals for blood glucose meters remained strong given the growing incidence of type 2 diabetes, which is linked to obesity, especially in emerging markets. Roche, best known for its cancer drugs, is also the world&;s biggest diagnostics company and the market leader in diabetes testing.

Go to Source

India’s ITC resumes cigarette production with larger health warnings

A man smokes a cigarette as he sits on a pavement along a road in SrinagarIndia&;s biggest cigarette maker, ITC Ltd, said on Monday it had resumed production in phases, complying with new rules on pictorial warnings from the federal government. The company had shut its plants from May 4 as it worked to get much larger health warnings on cigarette packs, even as a court hears objections to the new rules. "ITC cigarette factories have resumed production in a phased manner, with the specified 85 percent graphical warning pending hearing by the Karnataka High Court,?" a company spokesman told Reuters in an email.

Go to Source

1 79 80 81 82 83 125